Status:
COMPLETED
NFAT-regulated Gene Expression After Tacrolimus
Lead Sponsor:
Medical University of Graz
Conditions:
NFAT Regulated Gene Expression in Tacrolimus Treated Patients
Eligibility:
All Genders
18-90 years
Brief Summary
Aim of the study is measurement of NFAT-RGE (IL-2 (interleukin-2), IFN-γ (interferon-gamma), GM-CSF (granulocyte monocyte colony stimulating factor)) after tacrolimus (TAC) in de-novo immunosuppressed...
Detailed Description
The trial will be conducted as a prospective, longitudinal study. The study is a single-centre study performed at the Medical University of Graz, Department of Surgery, Division of Transplant Surgery ...
Eligibility Criteria
Inclusion
- Patients \> 18 years of age
- Liver transplantation
- Informed consent
Exclusion
- Patients \< 18 of years
- Patients taking actively part in a different interventional trial
Key Trial Info
Start Date :
January 18 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 29 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03315858
Start Date
January 18 2019
End Date
November 29 2021
Last Update
February 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz, Klin. Abteilung für Transplantationschirurgie
Graz, Austria, 8036